Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities
Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...
The American Journal of Managed Care4d
MagnetisMM-20: Priming Myeloma Tumor Cells for the Bispecific Bout
Pfizer), which targets B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells, in combination with carfilzomib, ...
The Scientist5d
The Art of Microbial Disguise
On the battleground of the human body, microbes use every skill to mask, infiltrate, manipulate, and evade the immune radar.
AZoLifeSciences on MSN6d
Programmable G-protein-coupled receptors redefine therapeutic applications.
This study demonstrates the development of PAGERs (programmable antigen-gated engineered receptors), combining antigen ...